Login / Signup

Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2).

Yan LiLing LiYong De PengGuang Yao SongShan Dong YeLi Ying DuJia Ning HouQiu He Ji
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
Eli Lilly and Company.
Keyphrases
  • end stage renal disease
  • type diabetes
  • ejection fraction
  • newly diagnosed
  • glycemic control
  • chronic kidney disease
  • randomized controlled trial
  • clinical trial
  • adipose tissue
  • study protocol